Testing the Safety and Effects of Radiation at Different Doses to Multiple Breast, Lung and Prostate Cancer Metastases

What we are studying

The purpose of this study is to test the safety of giving a few, focused, high doses of radiation (commonly referred to as stereotactic body radiotherapy [SBRT]) to all known sites of cancer within your body. This study will determine the recommended SBRT dose for each of the locations being treated. In this study the safety of SBRT to 3-4 cancerous deposits in any organ of the body will be tested. Additionally, this study will test the safety of giving SBRT to 2 cancerous deposits that are close together, or 2-3 cancerous deposits that are remaining following surgery to 1-2 other cancerous deposits.

Who we are studying

  • Men and Women
  • Races:
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Have received treatment to the breast or lung or prostate (the first location of cancer) and now the cancer has spread to other parts of the body that have not yet been treated.

What is involved

  • Receive radiation for about 1 to 3 weeks
  • After radiation treatment you will be followed by the study team on a regular basis for 2 years



Contact Information

Study Coordinator
Susan Moxley
Principal Investigator
Dr. Doris Brown

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.